Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome- MedGen UID:
- 815995
- •Concept ID:
- C3809665
- •
- Disease or Syndrome
Spastic paraplegia-79B (SPG79B) is an autosomal recessive progressive neurologic disorder characterized by onset of spastic paraplegia and optic atrophy in the first decade of life. Additional features are variable, but may include peripheral neuropathy, cerebellar ataxia, and cognitive impairment (summary by Rydning et al., 2017).
For a discussion of genetic heterogeneity of autosomal recessive spastic paraplegia, see SPG5A (270800).
Hereditary spastic paraplegia 72- MedGen UID:
- 816490
- •Concept ID:
- C3810160
- •
- Disease or Syndrome
Hereditary spastic paraplegia-72A (SPG72A) is a pure form of spastic paraplegia with onset of difficulty walking and stiff legs associated with hyperreflexia and extensor plantar responses in early childhood. The disorder is slowly progressive, and some patients develop the need for assistance in walking. Some patients may have pes cavus or sphincter disturbances. Cognition, speech, and ocular function are normal (summary by Esteves et al., 2014).
For a discussion of genetic heterogeneity of autosomal dominant spastic paraplegia, see SPG3A (182600).
Hereditary spastic paraplegia 62- MedGen UID:
- 924879
- •Concept ID:
- C4284588
- •
- Disease or Syndrome
A pure or complex form of hereditary spastic paraplegia with characteristics of onset in the first decade of life of spastic paraparesis (more prominent in lower than upper extremities) and unsteady gait, as well as increased deep tendon reflexes, amyotrophy, cerebellar ataxia and flexion contractures of the knees in some.
Spastic ataxia 9, autosomal recessive- MedGen UID:
- 1680026
- •Concept ID:
- C5193100
- •
- Disease or Syndrome
Hypervalinemia and hyperleucine-isoleucinemia- MedGen UID:
- 1719306
- •Concept ID:
- C5394277
- •
- Disease or Syndrome
Hypervalinemia and hyperleucine-isoleucinemia (HVLI) is a branched-chain amino acid metabolic disorder characterized by highly elevated plasma valine and leucine concentrations. The patient presented in adulthood with headache and mild memory impairment, and had abnormal symmetric white matter signals on brain MRI (Wang et al., 2015).
Spastic paraplegia 84, autosomal recessive- MedGen UID:
- 1794235
- •Concept ID:
- C5562025
- •
- Disease or Syndrome
PI4KA-related disorder is a clinically variable disorder characterized primarily by neurologic dysfunction (limb spasticity, developmental delay, intellectual disability, seizures, ataxia, nystagmus), gastrointestinal manifestations (multiple intestinal atresia, inflammatory bowel disease), and combined immunodeficiency (leukopenia, variable immunoglobulin defects). Age of onset is typically antenatal or in early childhood; individuals can present with any combination of these features. Rare individuals present with later-onset hereditary spastic paraplegia. Brain MRI findings can include hypomyelinating leukodystrophy, cerebellar hypoplasia/atrophy, thin or dysplastic corpus callosum, and/or perisylvian polymicrogyria.
Hereditary spastic paraplegia 9A- MedGen UID:
- 1800401
- •Concept ID:
- C5568978
- •
- Disease or Syndrome
Autosomal dominant spastic paraplegia-9A is a neurologic disorder characterized by onset of slowly progressive spasticity mainly affecting the lower limbs. The age at onset usually ranges from adolescence to adulthood, and patients have gait difficulties, motor neuropathy, and dysarthria. Additional variable features include cerebellar signs, cataract, pes cavus, and urinary urgency (summary by Coutelier et al., 2015).
For a general phenotypic description and a discussion of genetic heterogeneity of autosomal dominant spastic paraplegia, see SPG3A (182600).